| scholarly article | Q13442814 |
| P50 | author | Miriam Melis | Q85330553 |
| Marco Pistis | Q85330555 | ||
| Roberto Frau | Q43127453 | ||
| Silvia Fanni | Q59818090 | ||
| Marta De Felice | Q61479912 | ||
| P2093 | author name string | Anna Lisa Muntoni | |
| Paola Devoto | |||
| Sonia Aroni | |||
| P2860 | cites work | PPAR-alpha agonists as novel antiepileptic drugs: preclinical findings | Q21090748 |
| Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects | Q22248075 | ||
| Increased baseline occupancy of D2 receptors by dopamine in schizophrenia | Q24676113 | ||
| Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFkappa B and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR | Q28212718 | ||
| Using a maternal immune stimulation model of schizophrenia to study behavioral and neurobiological alterations over the developmental course. | Q30365823 | ||
| Targeting neurosteroid synthesis as a therapy for schizophrenia-related alterations induced by early psychosocial stress | Q30371274 | ||
| Maternal Immune Activation Disrupts Dopamine System in the Offspring | Q30377656 | ||
| Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy | Q30409382 | ||
| Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats. | Q30409892 | ||
| Inhibition of 17α-hydroxylase/C17,20 lyase reduces gating deficits consequent to dopaminergic activation. | Q30422089 | ||
| Sex effects on neurodevelopmental outcomes of innate immune activation during prenatal and neonatal life | Q30459901 | ||
| Schizophrenia and autism: both shared and disorder-specific pathogenesis via perinatal inflammation? | Q30468160 | ||
| Effect of peroxisome proliferator-activated receptor alpha activators on tumor necrosis factor expression in mice during endotoxemia. | Q33876924 | ||
| Prenatal maternal immune activation causes epigenetic differences in adolescent mouse brain. | Q34370478 | ||
| Pathway-Specific Dopamine Abnormalities in Schizophrenia | Q34527656 | ||
| Late Prenatal Immune Activation in Mice Leads to Behavioral and Neurochemical Abnormalities Relevant to the Negative Symptoms of Schizophrenia | Q34660546 | ||
| Endogenous fatty acid ethanolamides suppress nicotine-induced activation of mesolimbic dopamine neurons through nuclear receptors | Q35202878 | ||
| Glutamatergic afferents of the ventral tegmental area in the rat. | Q35460754 | ||
| Therapeutic prospects of PPARs in psychiatric disorders: a comprehensive review | Q95809249 | ||
| A Review of the Differences in Developmental, Psychiatric, and Medical Endophenotypes Between Males and Females with Autism Spectrum Disorder | Q35812632 | ||
| Gonadal steroid action and brain sex differentiation in the rat. | Q37396028 | ||
| From surface to nuclear receptors: the endocannabinoid family extends its assets | Q37694605 | ||
| Physiological role of peroxisome proliferator-activated receptors type α on dopamine systems. | Q38080161 | ||
| Prenatal poly(i:C) exposure and other developmental immune activation models in rodent systems. | Q38128464 | ||
| Macrophage-derived lipid agonists of PPAR-α as intrinsic controllers of inflammation | Q38639002 | ||
| PPARalpha ligands inhibit radiation-induced microglial inflammatory responses by negatively regulating NF-kappaB and AP-1 pathways | Q39929858 | ||
| Prenatal lipopolysaccharide induces hypothalamic dopaminergic hypoactivity and autistic-like behaviors: Repetitive self-grooming and stereotypies. | Q40205507 | ||
| Rationale for an adjunctive therapy with fenofibrate in pharmacoresistant nocturnal frontal lobe epilepsy | Q40491622 | ||
| Nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) is expressed in resting murine lymphocytes. The PPARalpha in T and B lymphocytes is both transactivation and transrepression competent | Q40765960 | ||
| Assessing the validity of an animal model of deficient sensorimotor gating in schizophrenic patients | Q40808959 | ||
| Prenatal LPS-exposure--a neurodevelopmental rat model of schizophrenia--differentially affects cognitive functions, myelination and parvalbumin expression in male and female offspring | Q41630045 | ||
| Sexually dimorphic effects of prenatal exposure to lipopolysaccharide, and prenatal and postnatal exposure to propionic acid, on acoustic startle response and prepulse inhibition in adolescent rats: relevance to autism spectrum disorders | Q41708487 | ||
| Polyunsaturated fatty acid deficiency during neurodevelopment in mice models the prodromal state of schizophrenia through epigenetic changes in nuclear receptor genes | Q42257168 | ||
| Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS. | Q42454049 | ||
| The modulatory mechanisms of fenofibrate on human primary T cells | Q43086366 | ||
| Increased synaptic dopamine function in associative regions of the striatum in schizophrenia | Q43145582 | ||
| A longitudinal examination of the neurodevelopmental impact of prenatal immune activation in mice reveals primary defects in dopaminergic development relevant to schizophrenia. | Q43182549 | ||
| Dopamine content and metabolism in mesencephalic and diencephalic cell cultures: sex differences and effects of sex steroids | Q43886711 | ||
| Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia | Q44515032 | ||
| Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia | Q44563200 | ||
| Ontogeny of sensorimotor gating and immune impairment induced by prenatal immune challenge in rats: implications for the etiopathology of schizophrenia | Q44647738 | ||
| Sex differences in densities of dopaminergic fibers and GABAergic neurons in the prenatal rat striatum | Q44706271 | ||
| Preliminary evidence for a modulation of fetal dopaminergic development by maternal immune activation during pregnancy | Q44788825 | ||
| Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia | Q44812893 | ||
| Electrophysiological properties of dopamine neurons in the ventral tegmental area of Sardinian alcohol-preferring rats | Q46382591 | ||
| Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. | Q46780371 | ||
| Antidepressant-like effects of fenofibrate in mice via the hippocampal brain-derived neurotrophic factor signalling pathway | Q47135495 | ||
| Use of fenofibrate during the first trimester of unplanned pregnancy in a patient with hypertriglyceridemia | Q47245946 | ||
| PPARα modulation of mesolimbic dopamine transmission rescues depression-related behaviors | Q47410292 | ||
| The Role of Nuclear Hormone Receptors in Cannabinoid Function | Q47926342 | ||
| Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort | Q47997393 | ||
| Gender differences in schizophrenia | Q48020725 | ||
| Estradiol derived from testosterone in prenatal life affects the development of catecholamine systems in the frontal cortex in the male rat. | Q48122665 | ||
| Prenatal lipopolysaccharide reduces social behavior in male offspring | Q48225271 | ||
| Protective activation of the endocannabinoid system during ischemia in dopamine neurons | Q48505122 | ||
| Prenatal development of mesencephalic and diencephalic dopaminergic systems in the male and female rat. | Q49014437 | ||
| Sexual differentiation of mesencephalic neurons in vitro: effects of sex and gonadal hormones | Q69413473 | ||
| Teratological study of the hypolipidaemic drugs etofylline clofibrate (VULM) and fenofibrate in Swiss mice | Q69619412 | ||
| Increased probability of GABA release during withdrawal from morphine | Q71955013 | ||
| Hyperlipidemia-associated pancreatitis in pregnancy managed with fenofibrate | Q83255124 | ||
| P433 | issue | 5 | |
| P921 | main subject | schizophrenia | Q41112 |
| P304 | page(s) | 549-561 | |
| P577 | publication date | 2018-11-21 | |
| P1433 | published in | CNS Neuroscience & Therapeutics | Q5013184 |
| P1476 | title | The PPARα agonist fenofibrate attenuates disruption of dopamine function in a maternal immune activation rat model of schizophrenia | |
| P478 | volume | 25 |
Search more.